B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 50.8 SEK 1.7% Market Closed
Market Cap: 3.3B SEK
Have any thoughts about
BioInvent International AB?
Write Note

BioInvent International AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioInvent International AB
Total Liabilities & Equity Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
BioInvent International AB
STO:BINV
Total Liabilities & Equity
kr1.1B
CAGR 3-Years
-11%
CAGR 5-Years
32%
CAGR 10-Years
27%
Biogaia AB
STO:BIOG B
Total Liabilities & Equity
kr2.3B
CAGR 3-Years
7%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Liabilities & Equity
kr778.7m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Liabilities & Equity
kr16.9B
CAGR 3-Years
40%
CAGR 5-Years
52%
CAGR 10-Years
41%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Liabilities & Equity
kr72.2B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
27%
BioArctic AB
STO:BIOA B
Total Liabilities & Equity
kr1.2B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is BioInvent International AB's Total Liabilities & Equity?
Total Liabilities & Equity
1.1B SEK

Based on the financial report for Sep 30, 2024, BioInvent International AB's Total Liabilities & Equity amounts to 1.1B SEK.

What is BioInvent International AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
27%

Over the last year, the Total Liabilities & Equity growth was -27%. The average annual Total Liabilities & Equity growth rates for BioInvent International AB have been -11% over the past three years , 32% over the past five years , and 27% over the past ten years .

Back to Top